News

Actual problems of HIV Infection: Mother and Child

09 Sep, 2020

Penta has been invited to run a one-day session at the Republican Hospital of Infectious Diseases, St Petersburg conference on ‘Actual problems of HIV Infection: Mother and Child’ on Tuesday…
Read More

NeoVanc trial in the final stretch towards completion!

07 Sep, 2020

The second trial in neonatal sepsis sponsored by Penta is now in its final stretch towards completion.
Read More

WSC Spotlight: Sepsis, Pandemics, and Antimicrobial Resistance – Global Health Threats of the 21st Century

03 Sep, 2020

Through 6 distinctive sessions, the WSC Spotlight will give an overview of the global epidemiology and burden of sepsis and AMR, exploring innovative, novel, and cost-effective approaches for the prevention…
Read More

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

20 Aug, 2020

Authors: Bollen PDJ, Moore C, Mujuru H, et al. The ODYSSEY Trial Team Published in: LANCET HIV. 2020;8:e533-e544 Date of publication: 20 August 2020   Download publication
Read More

A reason to SMILE – we reached Last Patient Last Visit

13 Aug, 2020

Last Patient Last Visit (LPLV) completed for the Penta 17 Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (SMILE) trial.
Read More

ODYSSEY trial data published in Lancet – shows increase in treatment options for older children living with HIV

06 Aug, 2020

Results from from the ongoing P1093 and ODYSSEY (PENTA20) studies, published in The Lancet HIV journal, show that children over 20kg in weight can safely take adult doses (50mg) of…
Read More

Harmonisation preserves research resources

29 Jul, 2020

A correspondence by Malte Kohns at St George’s University London to The Lancet Infectious Disease Journal, focusing on the importance of international collaboration.
Read More

Update on COVID-19 pandemic

22 Jul, 2020

20 July 2020 Update webinar by One Health Centre of Excellence
Read More

‘PentaTr@ining 2020: HIV & other Congenital Infections’ – Sign up today!

20 Jul, 2020

We are delighted to announce that registrations are now open for our online training course 'PentaTr@ining 2020: HIV & other Congenital Infections'.
Read More

EPIICAL in The Lancet: a new strategy to estimate the viral reservoir in HIV-infected children

16 Jul, 2020

Paolo Palma and his colleagues recently published in The Lancet HIV the paper “The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV”
Read More

EPPICC focus on COVID-19 impact on children and adolescents living with HIV

13 Jul, 2020

EPPICC was awarded a grant from the ViiV Global HIV and COVID-19 Emergency Fund to conduct research on the direct and indirect impact of COVID-19 on children and adolescents living…
Read More

Penta at the 23rd International AIDS Conference

06 Jul, 2020

The EPIICAL Project's contribution to the 23rd International AIDS Conference
Read More

New paper published in WHO Bulletin

02 Jul, 2020

Our collaborator Prof. Mike Sharland, together with GARDP and St. George’s, University of London researchers have just published a new paper in the WHO Bulletin investigating international antibiotic sales data…
Read More

ODYSSEY (Penta 20) trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children

01 Jul, 2020

Data from the ongoing P1093 and ODYSSEY (PENTA20) studies have led to the successful approval of ViiV Healthcare’s submission to the U.S. Food and Drug Administration (FDA) of the adult formulation…
Read More

HIV-exposed and uninfected children and adolescents focus in this year’s International AIDS Conference

30 Jun, 2020

Join the 6th Workshop on Children and Adolescents HIV-exposed and Uninfected (HEU) at 3pm (CEST) on 1st July 2020.
Read More

What did Penta get up to in 2019?

19 Jun, 2020

COVID-19, the new infectious disease which has uprooted our lives, social relationships and work habits, has turned out to be an unmissable opportunity to rethink our collaborative research and strive to drive attention…
Read More

COVID-19: what’s important to us

18 Jun, 2020

COVID-19, the new infectious disease which has uprooted our lives, social relationships and work habits, has turned out to be an unmissable opportunity to rethink our collaborative research and strive to drive attention…
Read More
1 9 10 11 12 13 23